Science to practice: Decrypting the enigma of ablation-induced off- target effects-is network pathway analysis the final piece of the puzzle?

Abstract

As part of the ongoing effort to better understand and mitigate prooncogenic off-target effects of imaging-guided radiofrequency ablation (RFA), Kumar et al (1) used gene expression and network pathway analysis to examine the gene activation profiles in the peri-ablational zone after RFA in a breast adenocarcinoma liver metastasis animal model. Their analysis identified STAT3 (signal transducer and activator of transcription 3) as a key transcription factor upregulated in many signaling pathways in the peri-ablational zone after RFA. Consequently, the authors successfully used two STAT3 inhibitors to reduce distant tumor growth after treatment with RFA. By demonstrating that judicious and appropriate adjuvant therapy helped contain distant tumor growth caused by ablation, Kumar et al have managed to pave the road ahead for the definitive success of ablation.